Funders › MA › Zoll Foundation Inc › 2022
Grants paid by Zoll Foundation Inc, tax year 2022
EIN 46-3630772 · Chelmsford, MA · Form 990-PF, Part XV · NTEE H12
In tax year 2022, Zoll Foundation Inc (EIN 46-3630772) reported 19 grants paid totaling $875,696. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2022
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2022 | Rosalind Franklin University of Medicine and Science North Chicago, IL | B | $98,520 | paid | AZIB SHAHIB, MD STUDY COVER RESEARCH ENTITLED "TRANSLATIONALLY RELEVANT SWINE MODEL OF LIPOPOLYSACCHARIDE-INDUCED SEPTIC SHOCK TO ASSESS A PERFUSION CENTERED APPROACH FOR THE MANAGEMENT OF SEPTIC SHOCK | 202300469349100610 |
| 2022 | Regents of the University of Mi Ann Arbor, MI | D | $73,818 | paid | DR. HSU SUPPORT RESEARCH ENTITLED IMPACT OF MASK APPLICATION ON AEROSOL GENERATION DURING CPR IN A SWINE CARDIAC ARREST MODEL | 202300469349100610 |
| 2022 | University of Pittsburgh Pittsburgh, PA | B | $50,000 | paid | JEREMY HERRMANN, MD STUDY OF "USE OF THE COLD SHOCK PROTEIN FIBROBLAST GROWTH FACTOR 21 TO ENHANCE HYPOTHERMIC NEUROPROTECTION IN THE RAT MODEL OF PEDIATRIC ASPHYXIAL CARDIAC ARREST" | 202300469349100610 |
| 2022 | Brigham and Women's Hospital Boston, MA | C | $50,000 | paid | TOMOYOSHI TAMURA MD STUDY IMMUNOMODULATORY THERAPY FOR TREATING BRAIN INJURY AFTER CARDIAC ARREST | 202300469349100610 |
| 2022 | Virginia Commonwealth University Richmond, VI | U | $50,000 | paid | JENNIFER BRADLEY, STUDY "EX VIVO USE OF A CELL-PERMEABLE SUCCINATE PRODRUG WILL RESCUE ISCHEMIA AND REPERFUSION INJURY TO MITOCHONDRIA AND CARDIAC FUNCTION IN THE DONATION AFTER CIRCULATORY DEATH HEARTS | 202300469349100610 |
| 2022 | The Feinstein Institute Manhasset, NY | U | $50,000 | paid | MUHAMMAD SHOAIB, MD SUPPORT RESEARCH ENTITLED, THE THERAPEUTIC POTENTIAL OF COMBINATIONAL LYSOPHOSPHATIDYLCHLOINE (LPC) THERAPY IN THE TREATMENT OF SEVERE INJURY RODENT CARDIAC ARREST | 202300469349100610 |
| 2022 | The General Hospital Corporation Boston, MA | C | $50,000 | paid | YUSUKE MIYAZAKI, MD, PHD SUPPORT RESEARCH ENTITLE, ROLE OF HEMOLYSIS AND NITRIC OXIDE CONSUMPTION AFTER CARDIAC ARREST | 202300469349100610 |
| 2022 | Stanford University Stanford, CA | C | $50,000 | paid | MELISSA VOGELSONG MD STUDY INFLUENCE OF SEDATION ON NEUROCOGNITIVE OUTCOMES AND QUALITY OF LIFE FOLLOWING EXTRACORPOREAL MEMBRANE OXYGENATION FOR CARDIAC ARREST AND POST-CARDIOTOMY SHOCK - BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 202300469349100610 |
| 2022 | Aarhus University Hospital | U | $49,230 | paid | PETER CAROE LIND MD STUDY NOVEL INSIGHTS INTO THE PREDICTION AND ETIOLOGY OF IN HOSPITAL CARDIAC ARREST | 202300469349100610 |
| 2022 | The Feinstein Institute Manhasset, NY | U | $49,112 | paid | PRIAM CHAKRABORTY MD STUDY "EFFECT OF THE RESUSCITATION QUALITY IMPROVEMENT PROGRAM ON CPR QUALITY IN OUT-OF-HOSPITAL CARDIAC ARREST" | 202300469349100610 |
| 2022 | University of Utah Salt Lake City, UT | B | $47,880 | paid | CHRISTOPHER KELLY, MD SUPPORT RESEARCH ENTITLED, NEBULIZED NITROGLYCERIN TO IMPROVE BLOOD FLOW DURING CARDIAC ARREST | 202300469349100610 |
| 2022 | Research Foundation for Suny Albany, NY | D | $47,740 | paid | BRIAN WEIL PHD STUDY INVESTIGATION OF MYOCARDIAN SYMPATHETIC DENERVATION AS A NOVEL MECHANISM OF ISCHEMIA-INDUCED PULSELESS ELECTRICAL ACTIVITY CARDIA ARREST" | 202300469349100610 |
| 2022 | University of Pittsburgh Pittsburgh, PA | B | $44,514 | paid | NADINE TALIA, MD SUPPORT TO RESEARCH ENTITLED REDUCTION OF PROTHROMBOTIC ANTIBODIES IN COVID 19 PATIENTS WHO RECEIVED CONVALESCENT PLASMA IN THE CLINICAL TRIAL | 202300469349100610 |
| 2022 | The Feinstein Institute Manhasset, NY | U | $38,321 | paid | DANIEL ROLSTON, MD SUPPORT RESEARCH ENTITLED, OPTIMIZING CHEST COMPRESSION: LOWER STERNUM REALLY IDEAL | 202300469349100610 |
| 2022 | National University Hospital (s) Pte Ltd | U | $36,800 | paid | SHIR LYNN LIM MD STUDY LIPIDOMICS FOR PROGNOSTICATION AFTER CARDIAC ARREST (LOGIC) STUDY - SINGAPORE | 202300469349100610 |
| 2022 | Children's Hospital of Philadelphia Philadelphia, PA | B | $31,810 | paid | LEAH CARR MD STUDY "AN INFORMATICS-DRIVEN APPROACH TO A MULTICENTER NEONATAL RESUSCITATION NETWORK" | 202300469349100610 |
| 2022 | University of Texas Science Center at Houston Houston, TX | U | $30,000 | paid | SUMMER CHAVEZ SUPPORT RESEARCH ENTITLED CHANGES IN ADULT OUT-OF-HOSPITAL CARDIAC ARREST OUTCOMES AND CONTRIBUTING FACTORS DURING COVID-19 PANDEMIC IN TEXAS | 202300469349100610 |
| 2022 | Mayo Clinic Rochester, MN | U | $16,020 | paid | DR SIMON ZEC STUDY "SAFETY AND FEASIBILITY OF KEFIR ADMIN IN CRITICALLY ILL ADULTS RECEIVING ANTIBIOTICS | 202300469349100610 |
| 2022 | Universitair Zickenhuis Gent Gent | U | $11,931 | paid | MAXIM VANWULPEN MD STUDY DETECTING INTRATHORACIC AIRWAY CLOSURE DURING PREHOSPITAL CARDIOPULMONARY RESUSCITATION - UNIVERSITY HOSPITAL GHENT | 202300469349100610 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.